Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
16.91
0.93 (5.82%)
At close: Aug 15, 2025, 3:59 PM
16.61
-1.75%
After-hours: Aug 15, 2025, 07:30 PM EDT
Arcutis Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 73.05M | 53.1M | 71.33M | 134.85M | 84.89M | 190.71M | 89.32M | 107.47M | 105.11M | 81.41M | 53.64M | 81.54M | 61.51M | 69.8M | 96.45M | 51.78M | 89.13M | 288.69M |
Short-Term Investments | 118.08M | 144.98M | 156.62M | 195.71M | 278.17M | 213.77M | 183.46M | 119.64M | 163.56M | 251M | 355.95M | 395.42M | 220.66M | 273.81M | 290.61M | 315.49M | 320.24M | 156.24M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 596K | 596K | 596K | 596K | 595K | 596K | 596K | 596K | 596K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K | 78K |
Receivables | 106.69M | 85.42M | 73.07M | 60.12M | 43.41M | 37.15M | 25.81M | 19.42M | 17.21M | 12.77M | 8.46M | 2.43M | n/a | 362K | n/a | 362K | 399K | n/a |
Inventory | 16.32M | 16.61M | 14.53M | 14.02M | 13.88M | 13.25M | 13.13M | 13.91M | 10.47M | 8.55M | 7.51M | 4.31M | n/a | n/a | 1.18M | n/a | n/a | 965K |
Other Current Assets | 7.74M | 11.85M | 8.82M | 19.02M | 3.15M | 617K | 9.53M | 925K | 3.09M | 2.8M | 4.46M | 1.23M | 1.23M | 1.23M | 1.54M | 1.54M | 1.54M | 2.12M |
Total Current Assets | 332.78M | 323.67M | 335.82M | 423.72M | 434.59M | 468.06M | 330.43M | 281.55M | 308.87M | 367.68M | 437.41M | 496.72M | 295.43M | 358.92M | 402.77M | 381.77M | 427.55M | 465.98M |
Property-Plant & Equipment | 3.12M | 3.34M | 2.99M | 3.25M | 3.51M | 3.63M | 3.9M | 4.19M | 4.41M | 4.7M | 4.6M | 4.74M | 4.96M | 5.11M | 5.3M | 5.16M | 5.26M | 5.36M |
Goodwill & Intangibles | 15.94M | 16.5M | 9.48M | 9.79M | 6.06M | 6.25M | 6.44M | 6.63M | 6.81M | 7M | 7.19M | 7.38M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 19.65M | 20.43M | 13.07M | 13.63M | 10.17M | 10.48M | 10.93M | 11.41M | 11.82M | 11.78M | 11.87M | 12.2M | 5.04M | 5.19M | 5.38M | 5.24M | 5.34M | 5.44M |
Total Assets | 352.43M | 344.11M | 348.89M | 437.35M | 444.76M | 478.54M | 341.37M | 292.96M | 320.69M | 379.46M | 449.27M | 508.91M | 300.46M | 364.11M | 408.15M | 387.01M | 432.89M | 471.42M |
Account Payables | 15.08M | 24.53M | 14.22M | 19.32M | 7.94M | 12.97M | 11.99M | 13.18M | 17.16M | 12.48M | 8.83M | 8.67M | 8.44M | 12.47M | 7.35M | 4.87M | 2.68M | 3.15M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1M | 842K | n/a | 99.51M | 777K | n/a | 735K | 715K | 695K | 676K | 657K | 639K | 582K | 507K | 433K | 306K | 106K | n/a |
Other Current Liabilities | 75.53M | 9.16M | 20.75M | 52.79M | 31.84M | n/a | 18.33M | 13.54M | 9.16M | 17.2M | 13.67M | 15.62M | 11.97M | 16.01M | 15.98M | 6.8M | 7.42M | 148K |
Total Current Liabilities | 103.94M | 91.13M | 81.01M | 172.43M | 51.35M | 47.31M | 46.67M | 41.89M | 36.66M | 37.02M | 37.81M | 37.1M | 27.48M | 32.96M | 33.33M | 19.06M | 13.35M | 15.31M |
Long-Term Debt | 107.05M | 107.62M | 107.2M | 105.09M | 203.81M | 202.8M | 201.8M | 200.78M | 199.77M | 198.76M | 197.77M | 196.75M | 73.14M | 72.74M | 72.35M | n/a | n/a | n/a |
Other Long-Term Liabilities | 360K | 360K | 570K | 420K | 194K | 306K | 849K | n/a | n/a | n/a | n/a | n/a | 12K | 19K | 25K | 31K | 25K | 58K |
Total Long-Term Liabilities | 109.52M | 110.32M | 110.33M | 108.29M | 206.98M | 206.29M | 206.03M | 204.35M | 203.52M | 202.7M | 201.89M | 201.04M | 77.6M | 77.37M | 77.15M | 4.96M | 5.06M | 5.11M |
Total Liabilities | 213.46M | 201.45M | 191.35M | 280.71M | 258.33M | 253.6M | 252.7M | 246.24M | 240.18M | 239.73M | 239.69M | 238.14M | 105.08M | 110.34M | 110.47M | 24.01M | 18.4M | 20.42M |
Total Debt | 110.16M | 110.8M | 110.58M | 208.18M | 207.56M | 206.74M | 205.92M | 205.07M | 204.22M | 203.38M | 202.54M | 201.68M | 78.17M | 77.86M | 77.56M | 5.23M | 5.14M | 5.05M |
Common Stock | 12K | 12K | 12K | 12K | 12K | 12K | 9K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K |
Retained Earnings | -1.16B | -1.15B | -1.12B | -1.11B | -1.07B | -1.02B | -981.9M | -915.62M | -870.86M | -799.86M | -719.76M | -647.75M | -540.04M | -472.63M | -408.31M | -336.98M | -280M | -237.99M |
Comprehensive Income | -35K | -140K | -7K | 533K | -294K | -133K | 4K | -184K | -292K | -414K | -1.09M | -1.6M | -1.25M | -1.02M | -255K | -18K | -36K | 42K |
Shareholders Equity | 138.97M | 142.66M | 157.54M | 156.64M | 186.43M | 224.94M | 88.67M | 46.72M | 80.51M | 139.73M | 209.58M | 270.77M | 195.38M | 253.77M | 297.68M | 363M | 414.49M | 450.99M |
Total Investments | 118.08M | 144.98M | 156.62M | 195.71M | 278.17M | 213.77M | 183.46M | 119.64M | 163.56M | 251M | 355.95M | 395.42M | 220.66M | 273.81M | 290.61M | 315.49M | 320.24M | 156.24M |